Rubicon Organics, Inc. · TSXV:ROMJ

Rubicon Organics — Investor Presentation (November 2026)

17 slides from Rubicon Organics's investor presentation, Nov 16, 2026

  1. Slide 1: Canada's Leading House of Premium Cannabis Brands

    INVESTOR PRESENTATION CANADA’S LEADING HOUSE OF PREMIUM CANNABIS BRANDS TSXV: ROMJ OTCQX: ROMJF 1

  2. Slide 2: Disclaimer

    DISCLAIMER This presentation is not, and under no circumstances is to be construed as, completion of facility upgrades and extraction capabilities on expected The production, packaging, labelling, handling, distribution, importation, a prospectus, or advertisement or a public offering of securities

  3. Slide 3: Rubicon Organics at a Glance

    RUBICON ORGANICS AT A GLANCE Vision: To be the most trusted house of premium cannabis brands, creating elevated experiences for people everywhere. # 1 Premium Licensed Producer in Canada1 Uniquely positioned: Craft at scale. 2 Cultivation facilities located in British Columbia, one of the world's mo

  4. Slide 4: Craft Quality at Commercial Scale

    CRAFT QUALITY AT COMMERCIAL SCALE Premium, BC-grown flower with cultivation optimized through a dual-facility model. PACIFICA, DELTA, BC CASCADIA, HOPE, BC 11,000 kg current annual capacity 4,500 kg annual capacity 15,500 kg estimated annual capacity by June 20271 Hybrid greenhouse Purpose-built ind

  5. Slide 5: Growth Trajectory

    GROWTH TRAJECTORY Consistent annual top-line and gross profit growth demonstrates strong demand and operational leverage. FIVE YEARS OF CONSISTENT GROWTH +17% YoY Q1 2021 to Q3 2026. All numbers in CAD. $20M Net Revenue Growth $15.6M in Q3 2025 → $18.3M in Q3 2026 $16M Seasonality results +20% $12M

  6. Slide 6: FY2025 Financial Overview

    FY2025 FINANCIAL OVERVIEW For the 12 months ending December 31, 2024 and 2025 | All figures in CAD METRIC FY2024 FY2025 YoY Change Net Revenue $48.7M $59.5M +22% GP Before FV Adjustments $15.3M $19.5M +27% Gross Margin Before FV Adjustments 31% 33% +2 Adjusted EBITDA1 $4.0M $5.0M +25% Net (Loss) Inc

  7. Slide 7: Q3 2026 Financial Overview

    Q3 2026 FINANCIAL OVERVIEW For the 3 months ending September 30, 2026 and 2025 | All figures in CAD METRIC Q3 2026 Q3 2025 YoY Change Net Revenue $18.3M $15.6M +17% Gross Profit before FV Adjustments $5.0M $5.3M -5% Gross Margin before FV Adjustments 27% 34% -600 bps Adjusted EBITDA1 $1.4M $1.7M -18

  8. Slide 8: Award-Winning Quality

    AWARD-WINNING QUALITY Accolades from budtenders, retailers, and industry evidence the leading quality and consistency that anchors Rubicon’s position in the premium segment. 2026 2025 2025 2025 2024 2024 Flower Craft Brand Flower Budtender Craft Brand Budtender of the Year of the Year of the Year Ch

  9. Slide 9: Global Market Expansion

    GLOBAL MARKET EXPANSION TOTAL ADDRESSABLE MARKET GROWTH 4 11.7% 10% + Active in largest and fastest-growing medical markets + International distributors and patients seeking reliable suppliers that can offer consistent quality new agreements with of Q3 2026 net of FY26 net revenue + Both Rubicon fac

  10. Slide 10: Optimizing Production

    OPTIMIZING PRODUCTION Pursuing strategic initiatives to reduce production costs and expand gross margins EXPANSION COMPLETE PRODUCTION TARGET: Q1 2027 Pre-Roll Automation In-House Hydrocarbon Extraction Automated pre-roll machines driving lower labour costs and higher gross margin in rapidly Bringin

  11. Slide 11: Optimizing Yield

    OPTIMIZING YIELD More grams per square foot from existing facilities. Anticipated 29% combined increase in biomass supply at high contribution margin ANNUAL PRODUCTION CAPACITY TARGET COMPLETION: JUNE 2027 ONGOING OPTIMIZATION CONTINUOUS Pacifica Lighting Fertilization & Strategic Genetic 15,500KG O

  12. Slide 12: Operational Execution: Cascadia

    OPERATIONAL EXECUTION: CASCADIA Proven ability to deliver major capital projects on time and on budget in a highly regulated industry. June 2025 Acquired to support unmet premium demand bringing Company annualized production CASCADIA FACILITY capacity to 15,500 kg October 2025 +4,500 kg Health Canad

  13. Slide 13: Proprietary Genetic Moat

    PROPRIETARY GENETIC MOAT GENETICS BRAND STRATEGY Our genetic library is a a strategic asset that cannot be easily replicated or acquired WHAT GENETICS DELIVER: World-Class Library of Higher Yields Cannabis Genetics Limited-release “drops” of rare Better Product Quality genetics 500+ Highly-Sought St

  14. Slide 14: Rubicon Management

    RUBICON MANAGEMENT Experienced management with a balance of CPG leadership and deep industry experience. Margaret Brodie, CPA, CA Melanie Ramsey Glen Ibbott CHIEF EXECUTIVE OFFICER & DIRECTOR CHIEF OPE RATING OFFICER CHIEF FINANCIAL OFFI CER CPA, CA. 10+ years in finance​. Over 10 years in 25+ years

  15. Slide 15: Rubicon Board of Directors

    RUBICON BOARD OF DIRECTORS Independent board oversight with extensive public company and industry backgrounds. Doris Bitz John Pigott Michael Detlefsen Jesse McConnell Margaret Brodie CHAIR DIRECTOR DIRECTOR DIRECTOR (NON-IND.) CEO & DIRECTOR (NON-IND.) 30+ years building, scalin g, an d 35+ years i

  16. Slide 16: Market Information

    MARKET INFORMATION AS OF NOV 13, 2026 # OF SHARES % 38% Amount held by Management & Insiders 28,679,667 38% Management 75.6M & Insiders Public Float 46,889,900 62% Shares Outstanding Total Outstanding 75,569,567 100% Options 1,520,200 RESEARCH COVERAGE Warrants 5,341,963 OPTIONS EXERCISE EXPIRING Re

  17. Slide 17: Contact Us

    CONTACT US Investor Relations www.rubiconorganics.com ir@rubiconorganics.com +1-437-929-1964 Rubicon Organics Inc 701-744 W. Hastings Street Vancouver, BC V6C 1A5 17

Rubicon Organics — Investor Presentation (November 2026) on 6ix